Related Experiment Video
Updated: Mar 25, 2026
09:11
Neurocircuit Assays for Seizures in Epilepsy Mutants of Drosophila
Published on: April 15, 2009
10.9K
[Dystrophinopathy and Seizure].
1Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|February 14, 2016
Summary
Dystrophinopathy often affects the central nervous system, with seizures occurring in 8% of patients. Specific mutations and dystrophin isoforms may increase seizure risk in these neurological disorders.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Context:
- Dystrophinopathy encompasses a spectrum of neuromuscular disorders.
- Central nervous system (CNS) manifestations are frequently observed in dystrophinopathies.
- Previous studies report varying incidences of febrile seizures and epilepsy in affected individuals.
Purpose:
- To investigate the prevalence of central nervous system manifestations, specifically febrile seizures and epilepsy, in patients with dystrophinopathy.
- To identify potential correlations between mutation location, dystrophin isoforms, and seizure occurrence.
- To explore the underlying molecular mechanisms potentially linking dystrophinopathies to neurological symptoms.
Summary:
- This study found that 8% of patients with dystrophinopathy experienced febrile seizures, with a higher incidence in those with mutations downstream of exon 45 (especially exon 63).
- Epilepsy was present in 5% of patients, being more common in Becker muscular dystrophy than Duchenne muscular dystrophy.
- Central nervous system expression of dystrophin isoforms Dp427 and Dp71 may contribute to seizure susceptibility through impaired GABAA receptors, aquaporin 4, and K channels.
Impact:
- Provides updated epidemiological data on CNS involvement in dystrophinopathy.
- Highlights specific genetic markers and dystrophin isoforms associated with increased seizure risk.
- Offers insights into the pathophysiology of neurological complications in dystrophinopathies, guiding future research and clinical management.
Related Concept Videos
01:13Seizures: Classification
2.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
01:24Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
01:21Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
01:28Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
01:20Inborn Errors of Metabolism
1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K